MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2019 International Congress

    Neural correlates of visual cues for gait impairment in Parkinson’s disease: a preliminary analysis

    S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)

    Objective: To examine the neural correlates of walking with visual cues in Parkinson’s disease (PD). Background: Gait impairment is central to PD with links to…
  • 2019 International Congress

    Circumstances of Falls in Single and Recurrent Fallers with Parkinson’s Disease

    I. Castro, H. Cavalcanti, G. Valença, J. Filho, L. Almeida (Salvador, Brazil)

    Objective: To compare the circumstances of falls among single fallers (1 fall over one year) and recurrent fallers (≥2 falls over one year) with Parkinson´s…
  • 2019 International Congress

    Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects

    A. Cronin-Golomb, O. Barthelemy, A. Marin, B. Davis, S. Alshuaib, T. Ellis, J. Degutis (Boston, MA, USA)

    Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…
  • 2019 International Congress

    A randomized clinical trial of multimodal balance training with rhythmical cues: effects on freezing of gait in Parkinson’s disease

    T. Capato, N. de Vries, J. Inthout, J. Ramjith, E. Barbosa, J. Nonnekes, B. Bloem (Nijmegen, Netherlands)

    Objective: To investigate whether the multimodal training is more effective in improving balance and gait in freezers versus non-freezers. Background: Non-pharmacological interventions are increasingly used…
  • 2019 International Congress

    Bumetanide to treat Parkinson’s disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and subthalamic deep brain stimulation: an open-label pilot study (BumFOG)

    P. Damier, W. Kamel, J. Al Hashel (Kuwait, Kuwait)

    Objective: to investigate the effects of bumetanide in  Parkinson's disease (PD) patients suffering from freezing of gait (FOG) resistant to dopamine replacement therapy and subthalamic…
  • 2019 International Congress

    Effects of Cognitively Challenging Agility Exercise Program on Clinical and Objective Measures in People with Parkinson’s Disease

    P. Carlson-Kuhta, N. Hasegawa, SH. Jung, V. Shah, A. Ragothaman, D. Peterson, K. Smulders, L. King, M. Mancini, J. Lapidus, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To investigate the effects of a 6-week cognitively challenging exercise intervention in people with Parkinson’s disease (PD). Background: Gait and balance impairments have been…
  • 2019 International Congress

    Hydrocephalic presentation of PSP and follow-up after ventricular-peritoneal shunting: Case report

    A. Taskinbayeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To report a patient with a rare clinical phenotype of Progressive Supranuclear Palsy (PSP) and describe 6 months follow-up results after surgical intervention. Background:…
  • 2019 International Congress

    Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Freezing of Gait After Deep Brain Stimulation in Parkinson’s Disease

    B. González, S. Jauma, R. Gomez, C. Marzal, M. Calopa (Hospitalet de Llobregat, Spain)

    Objective: The study of the benefit of intestinal levodopa/carbidopa infusion(LCIG) in resistant ON-freezing of gait(FOG-ON) that appears after Subthalamic Nucleus Deep Brain Stimulation(NST-DBS) in Parkinson’s…
  • 2019 International Congress

    Memantine and 3D gait analysis in patient with Parkinson’s disease: an observer-blind randomized clinical trial

    I. Miliukhina, E. Gracheva (Saint-Petersburg, Russian Federation)

    Objective: To examine the efficacy of memantine (20 mg), a non-competitive NMDAR antagonist, in the treatment of gait impairment in PD patients with mild cognitive…
  • 2018 International Congress

    Gait speed after applying anodal-transcranial Direct Current Stimulation in people with Parkinson’s disease? Preliminary results

    V. Alizad, M. Meinzer, L. Frossard, R. Polman, S. Smith, G. Kerr (Brisbane, Australia)

    Objective: The objective of this study was to explore the effects of anodal-tDCS with two different montages on gait speed in people with PD. Background:…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley